(redirected from vascular permeability factor)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia.


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
Lagrue, "The vascular permeability factor is a T lymphocyte product," Nephron, vol.
Nagy et al., "Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells," Journal of Investigative Dermatology, vol.
Vascular endothelial growth factor (VEGF), a potent angiogenic and vascular permeability factor [4], plays a significant role through inducing hyperpermeability of retinal vessels, breakdown of the blood-retinal barrier, and neovascularization [57]; moreover, VEGF antagonists are able to reduce retinal vascular permeability and neovascularization, thus inhibiting the development of DR [8, 9]; therefore VEGF may be strongly implicated in the progression of DR.
During the atherogenesis process, vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is released from macrophages within lesions (Ramos et al., 1998; Matsumoto and Mugishima, 2006).